The MGC Pharmaceuticals Ltd (ASX: MXC) share price has been smoking the market on Wednesday.
In afternoon trade the medicinal cannabis company’s shares are up 8% to 3.9 cents.
This latest gain means the MGC Pharma share price is now up almost 63% since the start of 2021.
Why is the MGC Pharma share price smoking the market today?
Investors have been buying MGC Pharma’s shares today following an update on its listing in the United Kingdom.
According to the release, the company’s shares were admitted to the standard sector of the London Stock Exchange (LSE) on Tuesday.
This admission follows the completion of a successful capital raise of 6.5 million pounds through an oversubscribed placement to UK based institutional funds, high net worth family offices, and professional investors.
This made MGC Pharma the first cannabis-sector company to IPO on the main market of the LSE in the United Kingdom.
Management advised that the net proceeds of the capital raise will be used to meet the costs associated with its priority clinical trials including ArtemiC and CannEpil. It will also be used to increase the distribution of its product range, general working capital, and the completion of its manufacturing facilities in Malta.
“Significant moment”
MGC Pharma’s Chief Executive and Managing Director, Roby Zomer, believes this is a significant moment for the company.
He said: “The LSE listing is a hugely significant moment for MGC Pharma, our admission to LSE follows the successful capital raising of £6.5 million which will be used to immediately commence the priority clinical research trials of our leading products, expand our distribution network into key sales markets, as well as advance the construction of our manufacturing facilities in Malta.”
“We are proud to make history as the first medical cannabis company on this historic Exchange. I would like to thank the MGC Pharma team and the advisors for all their hard work to make this happen. We look forward to updating our new and existing shareholders as we progress this programme,” he added.
This Tiny ASX Stock Could Be the Next Afterpay
One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…
Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.
Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!
See how you can find out the name of this stock
Returns as of 6th October 2020
More reading
- Coca-Cola just launched 100% recycled plastic bottles in North America
- Top brokers name 3 ASX shares to buy today
- The Blackearth Minerals (ASX:BEM) share price is rocketing 150% today. Here’s why
- Here’s why the Lendlease (ASX:LLC) share price is wobbling today
- Why the Megaport (ASX:MP1) share price is surging 7% higher today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Why the MGC Pharma (ASX:MXC) share price is smoking the market today appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3aIU8W8
Leave a Reply